You are now leaving this website.
Are you sure?
About Kedrion - Front Image




Kedrion editorial media


For Kedrion plasma is the raw material
that can be transformed into life-enhancing medicine.


Kedrion editorial media

Plasma can be separated from whole blood by removing the red and white blood cells and platelets. This is done by spinning the blood at high speed in a centrifuge.  The cells and platelets are forced to the bottom of the container and the plasma is collected off the top.  

Most people know about donating whole blood, a painless procedure that takes only about ten minutes (in addition to the time for preparation and recovery).  But one can donate plasma and only plasma in a procedure called plasmapheresis, during which blood drawn from the donor’s arm flows through a tube directly into a “plasmapheresis machine” in which the plasma is separated.  The blood cells and platelets are returned in a solution of saline through another tube directly back to the donor. This usually takes about 45 minutes, and plasma is rather quickly replenished in the body. The volume (typically between 650ml and 880ml) and frequency of donations are regulated by each country.  



Kedrion editorial media

After collection plasma is quickly frozen so it can be safely stored.  Plasma is used as raw material to obtain plasma-derived products.   To do this, plasma is separated into its various constituents in a process called fractionation.   The isolated proteins are refined and processed to create a number of plasma derivatives like clotting factors, albumin and immunoglobulin – medicinal products that are used to treat people suffering from a range of conditions like hemophilia and immune deficiency disorders.

Kedrion develops and creates these specialized protein therapies and distributes them in more than 90 countries. Partnering with donor and patient associations, the scientific community and healthcare systems, we Keep Life Flowing.  We practice and we encourage adaptation of, the highest therapeutic standards, while broadening global access to treatment.

Kedrion implements, maintains and documents its processes and activities in accordance with the highest standards of quality, including QSEAL (Quality Standards of Excellence, Assurance and Leadership) from the Plasma Protein Therapeutics Association (PPTA).